First In Human Study to Assess Safety and Efficacy of the ChampioNIR™ Drug Eluting Peripheral Stent in the Treatment of Patients With Superficial Femoral Artery Disease and/or Proximal Popliteal Artery Disease
for Superficial Femoral Artery Stenosis
3 locations incl. Atlanta
Sponsor: Medinol Ltd.
Sex: All·Age: 18 - 120
Code: NCT06410313·Recruiting